TPD52L2 and adrenal cortex carcinoma: For the PFI, high TPD52L2 expression predicted a worse PFI status in patients with ACC, BLCA, HNSC, KIRC, LGG, LIHC, LUSC, MESO, and PRAD (Figure 5D).